1. Home
  2. CCO vs ALDX Comparison

CCO vs ALDX Comparison

Compare CCO & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCO
  • ALDX
  • Stock Information
  • Founded
  • CCO 1995
  • ALDX 2004
  • Country
  • CCO United States
  • ALDX United States
  • Employees
  • CCO N/A
  • ALDX N/A
  • Industry
  • CCO Advertising
  • ALDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCO Consumer Discretionary
  • ALDX Health Care
  • Exchange
  • CCO Nasdaq
  • ALDX Nasdaq
  • Market Cap
  • CCO 472.0M
  • ALDX 398.3M
  • IPO Year
  • CCO 2005
  • ALDX 2014
  • Fundamental
  • Price
  • CCO $0.96
  • ALDX $2.19
  • Analyst Decision
  • CCO Buy
  • ALDX Strong Buy
  • Analyst Count
  • CCO 3
  • ALDX 3
  • Target Price
  • CCO $2.05
  • ALDX $9.67
  • AVG Volume (30 Days)
  • CCO 2.7M
  • ALDX 3.5M
  • Earning Date
  • CCO 05-01-2025
  • ALDX 05-01-2025
  • Dividend Yield
  • CCO N/A
  • ALDX N/A
  • EPS Growth
  • CCO N/A
  • ALDX N/A
  • EPS
  • CCO N/A
  • ALDX N/A
  • Revenue
  • CCO $1,505,230,000.00
  • ALDX N/A
  • Revenue This Year
  • CCO $6.83
  • ALDX N/A
  • Revenue Next Year
  • CCO $3.73
  • ALDX N/A
  • P/E Ratio
  • CCO N/A
  • ALDX N/A
  • Revenue Growth
  • CCO 4.95
  • ALDX N/A
  • 52 Week Low
  • CCO $0.81
  • ALDX $1.14
  • 52 Week High
  • CCO $1.88
  • ALDX $7.20
  • Technical
  • Relative Strength Index (RSI)
  • CCO 39.42
  • ALDX 29.45
  • Support Level
  • CCO $0.89
  • ALDX $1.99
  • Resistance Level
  • CCO $1.04
  • ALDX $2.36
  • Average True Range (ATR)
  • CCO 0.10
  • ALDX 0.44
  • MACD
  • CCO 0.00
  • ALDX -0.11
  • Stochastic Oscillator
  • CCO 44.12
  • ALDX 19.41

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: